Bray Capital Advisors’s Cognition Therapeutics CGTX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q4 | $1.58K | Hold |
2,250
| – | – | ﹤0.01% | 250 |
|
2024
Q3 | $1.05K | Hold |
2,250
| – | – | ﹤0.01% | 253 |
|
2024
Q2 | $3.74K | Hold |
2,250
| – | – | ﹤0.01% | 241 |
|
2024
Q1 | $4.1K | Hold |
2,250
| – | – | ﹤0.01% | 247 |
|
2023
Q4 | $4.16K | Hold |
2,250
| – | – | ﹤0.01% | 246 |
|
2023
Q3 | $3.24K | Hold |
2,250
| – | – | ﹤0.01% | 248 |
|
2023
Q2 | $4.12K | Hold |
2,250
| – | – | ﹤0.01% | 248 |
|
2023
Q1 | $4.46K | Hold |
2,250
| – | – | ﹤0.01% | 251 |
|
2022
Q4 | $4.73K | Hold |
2,250
| – | – | ﹤0.01% | 250 |
|
2022
Q3 | $4K | Hold |
2,250
| – | – | ﹤0.01% | 268 |
|
2022
Q2 | $5K | Buy |
+2,250
| New | +$5K | ﹤0.01% | 255 |
|
2022
Q1 | – | Sell |
-250
| Closed | -$2K | – | 277 |
|
2021
Q4 | $2K | Buy |
+250
| New | +$2K | ﹤0.01% | 269 |
|